Harrow Health, Inc.
USD41.79
+0.64 (+1.56%)
CEO
Mark L. Baum
IPO Date
2007-09-28
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$41.84
Prev. Close
$41.15
Day Low
$41.40
Day High
$42.92
52W Low
$28.54
52W High
$54.85
Market Cap
$1.56B
Volume
0.08M
| -68.4 |
| 31 Dec 2023 | FY | 69.6% | -18.7% | -34.7% | -7.8% | 2.71 | 2.82 | -15.0 |
| 31 Dec 2022 | FY | 71.3% | -15.9% | -51.0% | -9.0% | 4.07 | 6.35 | -28.8 |
| 31 Dec 2021 | FY | 74.9% | -24.8% | -159.6% | -18.3% | 6.91 | 6.24 | -12.8 |
| 31 Dec 2020 | FY | 70.4% | -6.9% | -12.3% | -5.8% | 0.87 | 3.79 | -52.9 |
| 31 Dec 2019 | FY | 67.3% | 0.3% | 0.6% | 0.3% | 0.76 | 2.99 | 1172.7 |
| 31 Dec 2018 | FY | 60.1% | 35.3% | 59.1% | 29.6% | 0.62 | 2.76 | 8.5 |
| 31 Dec 2017 | FY | 49.6% | -44.8% | -458.3% | -50.1% | 5.86 | 1.53 | -2.8 |
| 31 Dec 2016 | FY | 50.7% | -95.7% | -296.8% | -70.1% | 2.13 | 1.49 | -1.7 |
| 68.0 |
| 30 Sept 2025 | Q3 | 75.3% | 1.4% | 2.2% | 0.3% | 5.36 | 2.72 | 438.6 |
| 30 Jun 2025 | Q2 | 74.5% | 7.8% | 10.1% | 1.4% | 4.66 | 0.62 | 56.2 |
| 31 Mar 2025 | Q1 | 67.5% | -37.2% | -31.5% | -4.9% | 4.07 | 0.91 | -13.4 |
| 31 Dec 2024 | Q4 | 78.8% | 10.1% | 9.7% | 1.7% | 3.29 | 2.08 | 44.3 |
| 30 Sept 2024 | Q3 | 75.6% | -8.6% | -7.3% | -1.2% | 3.38 | 1.55 | -95.1 |
| 30 Jun 2024 | Q2 | 74.4% | -13.2% | -11.1% | -2.1% | 3.29 | 2.60 | -29.0 |
| 31 Mar 2024 | Q1 | 69.5% | -39.2% | -22.4% | -4.6% | 3.16 | 3.00 | -8.4 |
| 31 Dec 2023 | Q4 | 68.9% | -25.2% | -13.0% | -2.9% | 2.71 | 2.82 | -10.8 |